NCT05518903View on ClinicalTrials.gov

Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

November 15, 2022

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2028

Conditions
Localized Pancreatic AdenocarcinomaResectable Pancreatic Ductal AdenocarcinomaStage 0 Pancreatic Cancer AJCC v8Stage I Pancreatic Cancer AJCC v8Stage IIA Pancreatic Cancer AJCC v8
Interventions
PROCEDURE

Computed Tomography

Undergo CT

DRUG

Gallium Ga 68 FAPi-46

Given IV

PROCEDURE

Positron Emission Tomography

Undergo PET

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER